Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Aug;14(8):820-6.
doi: 10.1038/mp.2008.132. Epub 2008 Dec 9.

Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype

Affiliations
Comparative Study

Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype

J Loughead et al. Mol Psychiatry. 2009 Aug.

Abstract

The val allele of the catechol-O-methyltransferase (COMT) val(158)met polymorphism has been linked with nicotine dependence and with cognitive performance in healthy volunteers. We tested the hypothesis that the val allele is a risk factor for altered brain function and cognition during nicotine abstinence as compared with the normal smoking state. Chronic smokers (n=33) were genotyped prospectively for the COMT polymorphism for balanced selection of met/met, val/met and val/val groups. A visual N-back working memory task was performed during two separate blood oxygen level-dependent (BOLD) functional magnetic resonance imaging sessions in counterbalanced order: (1) smoking as usual, and (2)>or=14 h confirmed abstinence. Significant genotype by session interactions were observed for BOLD signal in right dorsolateral prefrontal cortex (DLPFC; (P=0.0005), left DLPFC (P=0.02) and dorsal cingulate/medial prefrontal cortex (P=0.01) as well as for task reaction time (P=0.03). Smokers with val/val genotypes were more sensitive to the abstinence challenge than carriers of the met allele, with the greatest effects on BOLD signal and performance speed at the highest working memory load. These data suggest a novel brain-behavior mechanism that may underlie the increased susceptibility to nicotine dependence and smoking relapse associated with the COMT val allele. Exploration of the effects of COMT inhibitors as a possible smoking cessation aid in this group may be warranted.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Visual N-back median reaction time difference scores. Median reaction time difference scores (N-back minus 0-back) for all responses show significant differences between the three genotype groups (Wald χ2(2) = 7.05, P = 0.03). Within the val/val group, there is a significant decrease in average response time during the smoking session for the 3-back condition, compared to abstinence.
Figure 2
Figure 2
Visual N-back working memory task activation. (a) Mean activation for abstinent and smoking sessions identified by a parametric model of increased working memory load (P≤0.05, corrected). Brain rendering performed with CARET. (b) Mean percent signal change (N-back minus 0-back) for the 1-back, 2-back and 3-back contrasts calculated from a priori regions of interest. Abstinence effects differed among the three genotype groups (Wald χ2(2) = 15.06, P = 0.0005).

References

    1. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA. 1998;95:9991–9996. - PMC - PubMed
    1. Huotari M, Gogos JA, Karayiorgou M, Koponen O, Forsberg M, Raasmaja A, et al. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. Eur J Neurosci. 2002;15:246–256. - PubMed
    1. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004;75:807–821. - PMC - PubMed
    1. Lachman H, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250. - PubMed
    1. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34:4202–4210. - PubMed

Publication types

MeSH terms

Substances